2021 annual financial data
Decoy Therapeutics 2021 Operating margin
Direct answer
Operating margin was -696.27%.
Operating income was -12,812,931 USD and net income was -12,768,238 USD.
Operating cash flow was -10,200,197 USD.
Get free Decoy Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,840,216 USD
- Operating income
- -12,812,931 USD
- Net income
- -12,768,238 USD
- Operating cash flow
- -10,200,197 USD